Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00012259 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire